![Susanne Toren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Susanne Toren.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Zürcher Kantonalbank (Broker)
![]() Zürcher Kantonalbank (Broker) Investment Banks/BrokersFinance Zürcher Kantonalbank (Broker) (ZKB-Broker) is the brokerage business unit of Zürcher Kantonalbank, a state-owned full-service bank founded in 1870, which is headquartered in Zurich, Switzerland. They conduct all investment activities in-house including financial advisory services, research, trading, and asset management. ZKB-Broker is an active trader in securities, foreign currencies, banknotes, precious metals, commodity contracts and financial derivatives on their own account and on behalf of third-party customers. The bank provides underwriting services in domestic debt and equity markets, sales and trading of listed domestic warrants and structured derivatives, and Swiss Franc foreign exchange trading. The firm offers round-the-clock market-making in credit default swaps from Swiss issuers. Their research covers a broad international investment universe and maintains a successful equity, bonds and sustainability research capability, together with independent investment fund research.
55
| Operating Division | Investment Banks/Brokers | 55 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Susanne Toren a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Banque Lombard Odier & Cie SA (Investment Management)
![]() Banque Lombard Odier & Cie SA (Investment Management) Investment ManagersFinance Banque Lombard Odier & Cie SA (Investment Management) (Lombard Odier-IM) is the investment management division of Banque Lombard Odier & Cie, a subsidiary of Compagnie Lombard Odier SCmA in Switzerland. The firm was founded in 2002 when Lombard Odier & Cie and Darier Hentsch & Cie. merged. They are headquartered in Geneva with branches and representative offices throughout Switzerland, Europe, the Americas, Asia Pacific and the Middle East. Lombard Odier-IM provides private banking and asset management services to institutions, family-owned businesses and high-net worth individuals. They also provide a range of support services for independent intermediaries. | Investment Managers | Portfolio Manager-Fixed Income | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
VP Bank (Schweiz) AG
![]() VP Bank (Schweiz) AG Investment ManagersFinance VP Bank (Schweiz) AG (VP Bank) is the private banking subsidiary of VP Bank AG (SW: VPBN) in Liechtenstein. Founded in 1975, they are based in Zurich and specialize in wealth management for individual clients. VP Bank manages a number of Liechtenstein-domiciled funds. | Investment Managers | Portfolio Manager-Equities | |
UBS AG (Investment Management)
![]() UBS AG (Investment Management) Investment ManagersFinance UBS AG (Investment Management) (UBS-IM) is the Swiss investment management division of UBS AG, itself a subsidiary of UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. Formerly known as UBS Global Asset Management Switzerland, the firm was founded in 1998 when Union Bank of Switzerland and Swiss Bank Corporation merged. Headquartered in Zurich and has additional office in Basel, UBS-IM manages a range of investment funds and offers investment management services for institutional, corporate and private clients. | Investment Managers | Analyst-Equity | |
Zürcher Kantonalbank
![]() Zürcher Kantonalbank Major BanksFinance Zürcher Kantonalbank engages in the provision of universal banking services. It offers its services through the following divisions: Private Banking, International Banking and Asset Management. The Private Banking division offers private advisory, asset management, fiduciary and other services. The International Banking division provides international payments and trade finance services. The Asset Management division includes segregated, balanced and overlay mandates. It also offers strategy advice and portfolio analysis services. The company was founded on February 15, 1870 and is headquartered in Zürich, Switzerland. | Major Banks | Chief Executive Officer | |
Vontobel Asset Management AG
![]() Vontobel Asset Management AG Investment ManagersFinance Vontobel Asset Management AG (Vontobel AM) is the asset management subsidiary of Vontobel Holding AG (SWX: VONN) in Switzerland. Founded in 1988, the firm is headquartered in Zurich and manages assets for institutional clients and the Vontobel Group's pension funds. Vontobel AM is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI). | Investment Managers | Analyst-Equity | |
SWISS PRIME SITE AG | Real Estate Development | Investor Relations Contact | |
LLB Asset Management AG
![]() LLB Asset Management AG Investment ManagersFinance LLB Asset Management AG (LLB-AM) is the wholly-owned subsidiary of state-owned Liechtensteinische Landesbank AG (SWX: LLB) in Liechtenstein. Formerly known as LLB Investment Partners, the firm was established in 2002 and is located in Liechtenstein. LLB-AM manages a range of funds for the parent bank and provides asset management services to institutions and high-net worth individuals. The firm's fellow subsidiary LLB Fund Services AG caters to the retail market. | Investment Managers | Portfolio Manager-Equities | |
Credit Suisse AG (Private Banking)
![]() Credit Suisse AG (Private Banking) Investment ManagersFinance Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations. | Investment Managers | Analyst-Equity Analyst-Fixed Income | |
University of St. Gallen | College/University | Masters Business Admin Graduate Degree | |
University of Basel | College/University | Graduate Degree | |
Bank Vontobel AG (Research Firm) | Investment Managers | Director of Research - Equity | |
UBS Securities (Asia) Ltd.
![]() UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Investment Banks/Brokers | Corporate Officer/Principal | |
Zürcher Kantonalbank (Investment Management)
![]() Zürcher Kantonalbank (Investment Management) Investment ManagersFinance Zürcher Kantonalbank (Investment Management) (ZKB-IM) is the investment management division of Zürcher Kantonalbank, a Swiss full-service bank headquartered in Zurich. Founded in 1870, ZKB-IM performs the bank's investment activities, including financial advisory services, research, trading, and asset management. The asset management division provides investment solutions for institutional, corporate and private clients, managing discretionary mandates and the ZKB range of mutual funds. Their mission includes fostering economic growth in the Canton of Zurich. | Investment Managers | Analyst-Equity Analyst-Equity Director of Investments Chief Executive Officer Analyst-Equity | |
Credit Suisse Securities Europe Ltd (Switzerland)
![]() Credit Suisse Securities Europe Ltd (Switzerland) Investment Banks/BrokersFinance Credit Suisse Securities Europe Ltd. (Switzerland) is the Swiss broker/dealer division of Credit Suisse Securities Europe Ltd. in Great Britain. They are ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Headquartered in Zurich, the firm offers equities and fixed income sales and trading services, and provides access to a range of debt and equity securities, derivative products and financing opportunities across the capital spectrum for corporate, sovereign and institutional clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Stifel Schweiz AG
![]() Stifel Schweiz AG Investment Banks/BrokersFinance Founded in 2003, Stifel Schweiz AG is a full-service investment bank. Part of Stifel Financial Corp., the Swiss company is headquartered in Zurich, Switzerland, with offices in multiple locations. The company provides a range of investment banking services. | Investment Banks/Brokers | Analyst-Equity | |
BioMedPartners AG
![]() BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Private Equity Investor | |
Lombard Odier Asset Management (Switzerland) SA
![]() Lombard Odier Asset Management (Switzerland) SA Investment ManagersFinance Lombard Odier Asset Management (Switzerland) SA (LOAM Switzerland) is an investment advisory subsidiary of Lombard Odier Investment Managers Holding SA, ultimately held by Compagnie Lombard Odier SCmA in Switzerland. Formerly known as 1798 Global Partners (Switzerland) SA, the firm was founded in 1972 by Aziz Nahas and Hubert Keller and changed their name to Lombard Odier Asset Management (Switzerland) in 2010. LOAM Switzerland is headquartered in Petit-Lancy, Geneva. | Investment Managers | Portfolio Manager-Fixed Income | |
Miracor Medical SA
![]() Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria. | Electronic Equipment/Instruments | Director/Board Member | |
Kizoo Technology Capital GmbH
![]() Kizoo Technology Capital GmbH Investment ManagersFinance Kizoo Technology Capital GmbH (KIZOO) is the venture capital arm of Atevia AG, itself a subsidiary of Cinetic Gesellschaft zur Entwicklung & Vertrieb von Medien. The firm was founded by Michael Greve, Matthias Hornberger, and Frank Schüler in 2006. It is headquartered in Karlsruhe, Germany. | Investment Managers | Private Equity Investor | |
Cell Medica Switzerland AG
![]() Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Deutsche Bank (Suisse) SA (Broker)
![]() Deutsche Bank (Suisse) SA (Broker) Investment Banks/BrokersFinance Deutsche Bank (Suisse) SA (Broker) (Deutsche Bank Switzerland) is the securities brokerage division of Switzerland-based Deutsche Bank (Suisse) SA, which is owned by Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in Zurich and was founded in 1980. Deutsche Bank Switzerland is responsible for macro and microanalysis within Deutsche Bank Group and acts as consultant for the bank, its clients and stakeholders. They analyze relevant trends for the bank in financial markets, the economy and society and highlight risks and opportunities. The firm delivers high-quality, independent analysis and actively promotes public debate on economic, fiscal, labor market and social policy issues. | Investment Banks/Brokers | President | |
Economiesuisse
![]() Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Verve Capital Partners AG
![]() Verve Capital Partners AG Investment ManagersFinance Verve Capital Partners AG operates as investment company with interests in European startup companies. The company was founded by Steffen Wagner and Lukas Weber in 2010 and is headquartered in Baar, Switzerland. | Investment Managers | Director/Board Member | |
Luzerner Kantonalbank AG (Private Banking)
![]() Luzerner Kantonalbank AG (Private Banking) Investment ManagersFinance Luzerner Kantonalbank AG (Private Banking) (LUKB-PB) is the private banking division of State of Lucerne-owned Luzerner Kantonalbank AG in Switzerland. Founded in 1850 as KantonaleSpar-und Leihkasse, the firm changed their name to Luzerner Kantonalbank in 1892. In 2006, they acquired private banking team Adler & Co. PrivatbankAG and in 2010 Adler & Co. PrivatbankAG merged into Luzerner Kantonalbank AG. LUKB-PB is based in Lucerne with an additional office in Zurich. They providesa full range of private banking services, including wealth management advice, for small and medium-sized enterprises in Canton Lucerne and the rest of German-speaking Switzerland. | Investment Managers | Analyst-Equity | |
Jomed AG | Corporate Officer/Principal | ||
APEIRON Biologics AG
![]() APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Biotechnology | Corporate Officer/Principal | |
Association of Swiss Cantonal Banks | Director/Board Member | ||
Aargauische Kantonalbank (Invt Mgmt)
![]() Aargauische Kantonalbank (Invt Mgmt) Investment ManagersFinance Aargauische Kantonalbank (Invt Mgmt) (AKB-IM) is the asset management division of state-owned Aargauische Kantonalbank, a cantonal bank headquartered in Aarau, Switzerland. Founded in 1913, AKB-IM provides investment advisory and management services to private and corporate clients. | Investment Managers | Analyst-Equity | |
Zürcher Volkswirtschaftliche Gesellschaft ZVG | Director/Board Member | ||
Bank J. Safra Sarasin AG (Broker)
![]() Bank J. Safra Sarasin AG (Broker) Investment Banks/BrokersFinance Bank J. Safra Sarasin AG (Broker) (Bank J. Safra Sarasin-Broker) is the brokerage division of Bank J. Safra Sarasin AG, a private bank headquartered in Basel, Switzerland. The firm was founded in 1841 and is a subsidiary of J. Safra Sarasin Holding AG, ultimately held by JS International Holdings Ltd. in the Bahamas. The firm is headquartered in Basel and. Bank J. Safra Sarasin-Broker offers brokerage services in securities, derivatives, currencies and precious metals for institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
Schweizerische Nationalbank (Investment Portfolio)
![]() Schweizerische Nationalbank (Investment Portfolio) Investment ManagersFinance Schweizerische Nationalbank (Investment Portfolio) (SNB-IP) is the investment portfolio division of Schweizerische Nationalbank (SW: SNBN) in Switzerland. The firm was founded in 1907 and is headquartered in Zurich. SNB-IP manages the assets of the Swiss National Bank, consisting of foreign currency, gold and Swiss francs, as determined by the established monetary order and the requirements of monetary policy. | Investment Managers | Economist | |
BC Platforms AG
![]() BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Data Processing Services | Director/Board Member | |
Mirabaud Securities Ltd. (Switzerland) | Investment Banks/Brokers | Analyst-Equity | |
Octavian AG
![]() Octavian AG Investment ManagersFinance Octavian AG is a Swiss company that specializes in equity market expertise and research for high alpha investors. The private company is based in Zurich, Switzerland. The company also facilitates high-quality investor events and are a trusted corporate finance advisor. Octavian was founded in 2017 by Dan Potashnick, Martin Schuler, René Saner, Serge Monnerat, Stephen Leventhal, Laura Pfeifer-Rossi, Alessandro Foletti. | Investment Managers | Analyst-Equity | |
JFG Life Sciences Stiftung der Universität Basel
![]() JFG Life Sciences Stiftung der Universität Basel Investment Trusts/Mutual FundsMiscellaneous JFG Life Sciences Stiftung der Universität Basel engages in the promotion of innovation transfer in the field of life sciences and related areas. It also supports knowledge and technology transfer at the University of Basel. The company was founded on December 20, 2018 and is headquartered Basel, Switzerland. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
UBS Asset Management Switzerland AG
![]() UBS Asset Management Switzerland AG Investment ManagersFinance UBS Asset Management Switzerland AG is the asset management subsidiary of UBS AG, ultimately owned by UBS Group AG (NYSE: UBS) in Switzerland. Headquartered in Zurich, the firm was founded in 2018 and provides investment management services to institutional investors, distribution partners and private investors. | Investment Managers | Analyst-Equity | |
Revel Pharmaceuticals, Inc.
![]() Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
LIfT BioSciences Ltd.
![]() LIfT BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer. | Miscellaneous Commercial Services | Director/Board Member | |
Sony Advanced Visual Sensing AG
![]() Sony Advanced Visual Sensing AG Electronic Production EquipmentElectronic Technology Sony Advanced Visual Sensing AG develops visual positioning systems applications for mobile devices. The company was founded by Christian Brändli and is headquartered in Zurich, Switzerland. | Electronic Production Equipment | Chief Executive Officer | |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Agrargenossenschaft Rom/meckl Eg
![]() Agrargenossenschaft Rom/meckl Eg Agricultural Commodities/MillingProcess Industries Agrargenossenschaft Rom/meckl Eg is a German company that engages in farming of crops. The private company is based in Rom, Germany. The CEO of the company is Volker Toparkus. | Agricultural Commodities/Milling | Director/Board Member |
Estadísticas
Internacional
Suiza | 40 |
Alemania | 5 |
Reino Unido | 3 |
Liechtenstein | 2 |
Hong-Kong | 2 |
Sectorial
Finance | 33 |
Health Technology | 5 |
Consumer Services | 3 |
Electronic Technology | 3 |
Commercial Services | 3 |
Operativa
Analyst-Equity | 64 |
Director/Board Member | 14 |
Market Strategist | 10 |
Corporate Officer/Principal | 10 |
Economist | 10 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Susanne Toren
- Conexiones Empresas